Reuters logo
BRIEF-Deciphera Pharma reports data from ongoing phase 1 clinical study of DCC-2618 
November 20, 2017 / 12:30 PM / in 24 days

BRIEF-Deciphera Pharma reports data from ongoing phase 1 clinical study of DCC-2618 

Nov 20 (Reuters) - Deciphera Pharmaceuticals Inc

* Deciphera Pharmaceuticals reports data from ongoing phase 1 clinical study of DCC-2618 at the 22nd annual scientific meeting and education day of the society for neuro-oncology Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below